Equity Research Miscellaneous Chemical Products

Should You Buy Arq, Inc. Stock in 2026?

By CirclFi Research Team · · 12/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Arq, Inc. (ARQ) occupies a solid middle-ground position with a Quality of Company score of 5.9/10. At the current market price of $2.09, the investment case depends heavily on whether our 13 independent valuation models indicate a discount to fair value.

The short answer: 5 of 12 CirclFi valuation models project upside for Arq, Inc. (ARQ) at $2.09 — the model consensus leans bearish, with a Quality Score of 5.9/10 and Value-Trap risk of 6/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 7 of 12 models suggest overvaluation — majority bearish
  • Quality Score: 5.9/10 — Moderate — mixed signals
  • Value Trap Risk: 6/100 — Minimal — healthy fundamentals
  • Fair Value Range: $0.08 – $8.72 (10441% spread)

Bullish Models

5 / 12

Bearish Models

7 / 12

Quality Score

5.9 /10

Moderate — mixed signals

Value Trap Risk

6 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

12 /13
Active Models

Avg. confidence: 37%

Investment Thesis

The Bull Case

Target: $8.72 (+317.2% upside)

  • According to the CirclFi Deep Alpha Valuation Engine, 5 of 12 models identify upside from $2.09 to a composite fair value of $2.31, indicating the market hasn't fully priced in Arq, Inc.'s earnings power.
  • According to the CirclFi Deep Alpha Valuation Engine, the First Chicago model targets a fair value of $8.72 (+317.2%), anchoring the bull case with a methodology that evaluates base, bull, and bear scenarios simultaneously.
  • Industry tailwind: reshoring and supply chain localization could provide meaningful support for Arq, Inc.'s revenue and margin trajectory in the Miscellaneous Chemical Products space.

The Bear Case

Target: $0.08 (-96.0%)

  • According to the CirclFi Deep Alpha Valuation Engine, the Sentiment SOTP model sees the stock as overvalued with a fair value of $0.08 (-96.0%), suggesting that the market price embeds overly optimistic growth assumptions.
  • According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +413.2% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology.
  • Industry headwind: cyclical demand downturn represents a meaningful risk for Arq, Inc. and its Miscellaneous Chemical Products peers.

Peer Benchmarking

CBT Cabot Corporation
9.7
WDFC WD-40 Company
9.5
ESI Element Solutions In
9.4
FTK Flotek Industries, I
7.6
FSI Flexible Solutions I
7.5

Valuation Divergence

Spread

10441%

Fair Value Range

$0.08 – $8.72

A 10441% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

First Chicago

$8.72 (+317.2%)

Most Bearish

Sentiment SOTP

$0.08 (-96.0%)

Key Risk Factors

Model Disagreement

10441% spread signals high variance in projections.

Bearish Consensus

7/12 models suggest overvaluation.

Macro/Sector Risk

Miscellaneous Chemical Products headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View ARQ Data Page →

The Bottom Line

Arq, Inc. at $2.09 is a genuine coin-flip in our framework. The 5–6 bull-bear split across 12 models, +413.2% model spread, and composite fair value of $2.31 (+10.5% avg.) argue for a watchlist position rather than a high-conviction bet. Quality at 5.9/10 adds additional caution to the mix.

These are quantitative model outputs, not investment recommendations. Arq, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

Frequently Asked Questions

Should I buy ARQ stock right now?

Based on CirclFi's multi-model analysis, 5 of 12 models see upside for ARQ at $2.09. The models are divided, which means the investment case depends heavily on your assumptions about Arq, Inc.'s future. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Arq, Inc.?

Key risks include: wide model disagreement (10441% spread), signaling high uncertainty; general market and sector-specific risks affecting Miscellaneous Chemical Products companies. Always diversify and consult a financial advisor.

How does ARQ compare to its competitors?

Among Miscellaneous Chemical Products peers, ARQ holds a Quality Score of 5.9/10. Comparable companies include CBT (QOC 9.7), WDFC (QOC 9.5), ESI (QOC 9.4). The relative ranking helps investors identify whether ARQ offers better fundamental quality than alternatives in the same sector.

Is ARQ a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. ARQ's Quality Score of 5.9/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.

What price should I buy ARQ at?

CirclFi does not provide target buy prices or price alerts. However, our 12 active models produce fair value estimates ranging from $0.08 to $8.72. At $2.09, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for ARQ.

View ARQ Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →